IMC Chicago’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.17M Buy
162,300
+83,700
+106% +$1.21M ﹤0.01% 3074
2026
Q2
$1.17M Buy
78,600
+57,500
+273% +$619K ﹤0.01% 3664
2026
Q1
$179K Sell
21,100
-56,000
-73% -$613K ﹤0.01% 5087
2025
Q4
$870K Buy
77,100
+40,800
+112% +$505K ﹤0.01% 3094
2025
Q3
$545K Buy
+36,300
New +$528K ﹤0.01% 3109

Other funds holding BHVN

IMC Chicago's BHVN Position: Q3 2026 in Review

IMC Chicago increased its Biohaven (BHVN) stake by 199% in Q3 2026, buying an estimated $2.42M and bringing the position to 251,416 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2627.

IMC Chicago first reported a position in BHVN in Q4 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • IMC Chicago held 251,416 shares of Biohaven worth $3.36M as of Q3 2026.
  • IMC Chicago bought 167,215 Biohaven shares in Q3 2026, an estimated $2.42M.
  • Biohaven made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2627 holding.
  • IMC Chicago first reported a position in Biohaven in Q4 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.